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A membrane-anchored aptamer sensor for
probing IFNc secretion by single cells†
Liping Qiu,ab Florian Wimmers, b Jorieke Weiden, b Hans A. Heus,c
Jurjen Tel ‡*bde and Carl G. Figdor ‡*b
Insight into the behavior of individual immune cells, in particular
cytokine secretion, will contribute to a more fundamental under-
standing of the immune system. In this work, we have developed a
cell membrane-anchored sensor for the detection of cytokines
secreted by single cells using a combination of aptamer-based
sensors and droplet microfluidics.
Cellular heterogeneity is considered a hallmark of biological
systems and has significant impact on various cellular processes
especially in the immune system.1,2 Key immunological functions
such as the activation of NF-kB3 or the induction of anti-viral
immunity4 emerge as heterogeneous processes and can display
digital behaviour. Insight into immune cell behaviour, and in
particular cytokine secretion, at the single-cell level is important to
define cell-to-cell variation and to get a better understanding of
how individual immune cells can contribute to and control global
immune responses.5 So far, most experimental approaches,
e.g. enzyme-linked immunosorbent assay (ELISA), only yield the
global outcome of the bulk population, potentially blending and
masking the unique contributions of individual cells.6,7 This
problem is particularly pronounced in immunology where the
outputs of immune responses are often combined behaviours of
highly heterogeneous ensembles of cells. Although antibody-based
flow cytometry assays are able to perform single cell cytokine
readouts, they are designed as end-point assays and cannot be
used to monitor cytokine production with high spatiotemporal
resolution.
Microfluidics enable the generation of picolitre water-in-oil
droplets which serve as a versatile platform for the development of
low-cost and high-throughput single-cell analysis tools.8–10
While microfluidic systems have been successfully used to
compartmentalize individual cells dating back to the 1950s,
the lack of easy-to-handle detection techniques with on-line
implementation, high sensitivity, high selectivity and a ‘‘signal-
on’’ reporting mechanism has hampered the development of
droplet-based single cell research.11 These challenges may be
addressed by exploiting aptamers as biosensors. Aptamers are
artificial nucleic acids generated through an in vitro selection
method based on their specific binding with target molecules.12,13
In addition to their high binding affinity and high specificity,
aptamers have the intrinsic advantages of flexible design, simple
synthesis and convenient modification, making them promising
molecular tools for the development of novel biological assays.14,15
Meanwhile, cytokine secretion by immune cells is a transient
biological process with rapid fluctuation.16 Cell membrane-
anchored aptamer sensors, which directly measure cytokines
produced by a cell, have a high potential for accurate real-time
monitoring of cellular functions.17,18
In this work, we developed a cell membrane-anchored
fluorescent aptamer sensor and combined it with a droplet-
microfluidic platform to detect cytokine secretion at the single-cell
level (Scheme 1). As a proof of concept, the type II interferon
(IFNg),19 a cytokine that is critical for both innate and adaptive
immunity against a broad range of threats, was used as the
target cytokine. An IFNg-specific aptamer20 was used as the
recognition unit. The 30 end of the IFNg aptamer was extended
with a short DNA sequence (9 mer, termed as cDNA1) which was
complementary to the 50-end section of the aptamer. This
extended aptamer could self-hybridize into a hairpin structure.
For fluorescence signalling, its two ends were separately labelled
with a ROX fluorophore and a TAO quencher. At the initiation
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stage, ROX and TAO were kept in close proximity due to the
formation of the hairpin structure, resulting in quenched
fluorescence. Upon binding with IFNg, the aptamer probe (AP)
will switch into a specific tertiary structure, separating the
fluorophore from the quencher, thus leading to restoration of
the fluorescence. To engineer a cell-surface aptamer sensor, the
50-end of AP was linked to a cholesterol tail. Based on hydro-
phobic interaction between the cholesterol tail and the cellular
phospholipid layer, the AP can be eﬃciently anchored onto the
membrane.21 This cell membrane-anchored AP can directly
probe the extracellular microenvironment, thus enabling the
detection of cytokine secretion by immune cells. Finally, single
aptamer-decorated T cells were encapsulated in droplets (65 pL)
and stimulated, which allowed us to probe the cytokine produc-
tion of single cells with high throughput.
The specific response of the cholesterol-linked aptamer probe
(CLAP) to IFNg was first evaluated in a buﬀer solution by
fluorescence spectroscopy. As shown in Fig. 1A, the ROX fluores-
cence intensity (at 605 nm) enhanced gradually when increasing
the IFNg concentration from 17.2 nM to 550.0 nM. The detection
limit was approximately 10.0 nM (equal to 14.5 ng mL1), which
correlated well with previously reported results,20 indicating that
the linkage of a cholesterol tail to the end of the aptamer
sequence is not sterically hindering and as such has no negative
impact on the sensing performance of the AP. Since the extra-
cellular microenvironment of activated immune cells usually
contains various cytokines, it was necessary to test the specificity
of this CLAP. For all tested non-target cytokines, including a type
I IFN (IFNa), we observed only very weak fluorescence signals
which hardly exceeded background levels (Fig. 1B), verifying
excellent detection selectivity of this aptamer probe.
Next, we evaluated the membrane anchor eﬃciency of the
CLAP. Primary T cells isolated from human peripheral blood
mononuclear cells (PBMCs) were used as a model cell type. In
order to detect a fluorescence signal that indicates successful
membrane anchoring of CLAP, a fully complementary DNA
(termed as cDNA2) of the AP was added to separate the
fluorophore and the quencher through the formation of a
CLAP/cDNA hybrid. To optimize the membrane anchor process,
the T cells were incubated with the CLAP/cDNA hybrid at
diﬀerent concentrations at room temperature (RT) for 10 min,
washed and subsequently analysed by flow cytometry. As shown
in Fig. 2A, a significant dose-dependent fluorescence increment
was observed, and the fluorescence enhancement gradually
plateaued after the probe concentration exceeded 0.5 mM. Next,
we studied the incubation time of the cells with the CLAP/cDNA
hybrid. The fluorescence signal reached saturation after
2.5 min, indicating an extremely eﬃcient cell membrane
anchor eﬃciency of CLAP (Fig. 2B). To guarantee consistent
cell surface modification, a CLAP concentration of 1 mM and an
incubation time of 10 min were used in all subsequent experi-
ments. The surface density of the probe was measured using
fluorescence spectrometry (data not shown), and a density of
B0.62  106 probes per cell was obtained corresponding to a
cell surface coverage of 5.1% (the surface coverage was
Scheme 1 Schematic illustration of a T cell-surface aptamer sensor for
measuring cytokine secretion at the single-cell level. The cholesterol-
linked aptamer probe (CLAP) can eﬃciently anchor onto the cell surface
based on the hydrophobic interaction between the cholesterol tail and the
cellular phospholipid layer. Upon binding of the secreted target cytokine,
the fluorescence of the aptamer probe will be turned on. By using the
microfluidic chip system, the aptamer-decorated T cells could be individually
encapsulated into droplets, thus enabling the detection of the cytokine
secretion at the single-cell level.
Fig. 1 Fluorescence spectra of the aptamer probe (200 nM) with the
addition of IFNg at diﬀerent concentrations; inset: plot of peak fluores-
cence intensity at 605 nm versus the IFNg concentration. (B) Selectivity of
the aptamer probe. The concentrations of IFNg and other competing
cytokines were all 400 nM. The fluorescence signal in response to IFNg
was defined as 100%, while those in response to other cytokines were
calculated accordingly. Error bars represent the standard deviation of three
independent experiments.
Fig. 2 (A) Flow cytometry assay of T cells incubated with the CLAP/cDNA
hybrid of diﬀerent concentrations at RT for 10 min. (B) Flow cytometry
assay of T cells after incubation with the CLAP/cDNA hybrid (1 mM) at RT for
diﬀerent time spans. (C) Confocal microscopy images of T cells after
incubation with the CLAP/cDNA hybrid (1 mM) at RT for 10 min. Scale bar
represents 10 mm.
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calculated by assuming a cell diameter of 7 mm and a DNA
probe diameter of 2 nm). The cellular location of CLAP was
visualized by confocal microscopy.
Fig. 2C shows a significant and uniform fluorescence signal
on the cell membrane, providing additional proof for the
successful fabrication and surface integration of the cell
membrane-anchored aptamer probe.
Having successfully engineered a membrane-anchored AP,
we proceeded to evaluate its ability to detect IFNg in the
extracellular microenvironment by confocal microscopy. For
that purpose, non-activated T cells were decorated with CLAP
and resuspended in the culture medium. After the addition of
soluble recombinant IFNg (600 nM), the membrane of T cells
lighted up instantly, whereas little fluorescence was detected in the
absence of IFNg (Fig. 3A). To further confirm IFNg-dependent
fluorescence as measured by confocal microscopy, we exploited
flow cytometry which allows high-throughput analysis of a large
number of cells. A clear peak shift in the fluorescence intensity was
observed in the presence of IFNg, confirming that CLAP is a
powerful and reliable molecular tool for the online detection of
IFNg (Fig. 3B).
To challenge whether this cell membrane-anchored AP can
be used to monitor IFNg secretion, T cells were activated by
phorbol myristate acetate (PMA, 0.05 mg mL1) and ionomycin
(1 mg mL1) in order to stimulate cytokine secretion.22 The AP
was anchored onto the T cell membrane, and the fluorescence
intensity was measured using flow cytometry at diﬀerent time
points after stimulation. Strikingly, the fluorescence signal
enhanced gradually upon immune stimulation (Fig. 3C). In
contrast, negligible fluorescence changes were observed in the
unstimulated (control) T cell samples. As confirmed by ELISA,
T cells started to secret IFNg two hours after stimulation and
the secretion gradually increased when extending the stimula-
tion time (Fig. S1, ESI†). The results obtained by the current cell
membrane-anchored aptamer probe were comparable with
those obtained by the commercial ELISA kit, indicating reliable
analysis and performance of this aptamer-based sensing sys-
tem (Fig. 3D). To control the spontaneous activation of the
CLAP, we used an immortalized mouse dendritic cell, JAWS II,
which was unable to secret human IFNg (as demonstrated by
ELISA, data not shown). As expected, no fluorescence change of
the aptamer-decorated JAWS II cells was observed after stimu-
lation (Fig. S2, ESI†). Together, these results demonstrate that
the current cell membrane-anchored AP is able to specifically
detect IFNg secretion by activated T cells.
To test whether the developed AP would be suitable as a tool
for the real-time monitoring of cytokine production by indivi-
dually activated immune cells in droplets, we set up a single cell
analysis platform based on droplet microfluidics. For this
purpose, a microfluidic PDMS chip system composed of two
aqueous-phase streams and one organic-phase stream was
used. The two aqueous-phase streams separately delivered
aptamer probe-anchored cells and immune stimuli, and were
mixed prior to the droplet formation junction (Scheme 1). The
organic-phase stream was connected directly to the droplet
generator to form discrete water-in-oil droplets (Fig. S3, ESI†).
To obtain the highest single-cell encapsulation eﬃciency, the
starting cell concentration was optimized and strictly fixed at
2.6  106 cells per mL.9 Under these conditions, approximately
15% of the droplets were loaded with only one cell, and the
fraction loaded with more than one cell was less than 2%. Our
previous work has demonstrated that these picolitre droplets
provide a biocompatible environment and suﬃcient nutrients
for cells to grow for more than 48 h.9 The cell-containing
droplets were collected, placed on a glass slide and imaged
using a fluorescence microscope. As shown in Fig. 4A, uniform
and mono-disperse water-in-oil droplets were obtained; some
of them encapsulated single cells (as indicated by the yellow
arrow). Using a high-resolution confocal microscope (inset of
Fig. 4A), we could show that the aptamer derived fluorescence
signal was localized on the cell membrane, indicating the
successful fabrication of a cell-surface sensor-based single cell
analysis platform. To detect the cytokine secretion of individual
cells, the collected droplets were incubated at 37 1C with 5%
CO2 for 6 hours and then imaged by fluorescence microscopy.
As shown in Fig. 4B, a stronger fluorescence signal was
observed from the activated T cells, in comparison to that from
the unstimulated T cells. As measured using the ImageJ soft-
ware, the background-subtracted fluorescence intensity from
the stimulated T cells was significantly higher than that from
the unstimulated T cells (Fig. 4C). To further confirm these
results, the encapsulated cells were collected by breaking the
emulsion using perfluorooctanol (PFO) and then analysed by
flow cytometry. In line with the microscopy results, a clear
Fig. 3 Potential of a T cell membrane-anchored biosensor for IFNg
detection. (A) Confocal microscopy images of T cells modified with the
aptamer probe and then treated with 600 nM IFNg (ii), or buﬀer only as a
control (i). Scale bar represents 10 mm. (B) Flow cytometry assay of T cells
modified with the aptamer probe after the addition of 600 nM IFNg, or
buﬀer only as a control. (C) Flow cytometry assay of aptamer decorated-T
cells with (left) or without (right) stimulation of PMA/ionomycin for diﬀer-
ent time periods. (D) Corresponding kinetic flow cytometry assay of T cells
stimulated with PMA/ionomycin at diﬀerent time intervals. Error bars
represent the standard deviation of three independent experiments.
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fluorescence peak shift was observed from the single stimu-
lated T cells. Taken together, all these results demonstrate that
the AP-based droplet-microfluidic assay, presented here, can be
used to detect cytokine secretion at the single-cell level.
In summary, by exploiting an aptamer as a detection unit,
we developed a cell membrane-anchored sensor for detecting
cytokine secretion by human immune cells in the extracellular
microenvironment. Moreover, in combination with a droplet-
based microfluidic system, we have successfully encapsulated
single AP-decorated T cells into picoliter droplets. Taking
advantage of the simple operation, high throughput, high
spatiotemporal resolution and a ‘‘signal on’’ mechanism, this
droplet-based aptamer sensing platform was able to detect
cytokine secretion at the single-cell level, positioning it as a
powerful addition to the armamentarium for studying immune
response at the single-cell level.
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